ZymoGenetics: Biology is basic

Although ZymoGenetics Inc. now has both independence and a $150 million war chest with which to bolster its discovery engine, the company will steer clear of becoming a target provider with high-throughput genomics capabilities, aiming instead to exploit its biology roots in protein therapeutics.

ZymoGenetics (Seattle, Wash.) had operated for the past

Read the full 517 word article

How to gain access

Continue reading with a
two-week free trial.